相关实验视频
Updated: Jun 12, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.8K
个性化治疗方法可以改善2型糖尿病的血糖指数
Eguono Deborah Akpoveta1, Uchenna E Okpete2, Haewon Byeon3
1Department of Community Medicine, Federal Medical Centre, Asaba 322022, Delta state, Nigeria.
World journal of diabetes
|June 9, 2025
概括
个性化护理改善了2型糖尿病的管理,特别是在新诊断的患者中. 持续高血糖 (糖化血红蛋白≥10%) 带来了挑战,突出了针对性干预措施的需要,而不是一种适合所有人的方法.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 公共卫生 公共卫生
背景情况:
- 2型糖尿病 (T2DM) 的管理是具有挑战性的,特别是在血糖控制不佳的情况下.
- 血糖调节不足有助于糖尿病并发症,并引起公众健康的关注.
- 对于控制不良的各种T2DM子组的密集干预的证据有限.
研究的目的:
- 评估血糖史对不良控制的T2DM治疗结果的影响.
- 为了比较个性化与通用化护理模型的有效性.
- 为了确定不同对干预措施的反应不同的患者子组.
主要方法:
- 未来研究设计. 未来研究设计.
- 基于血糖史和控制水平的治疗结果的分析.
- 通过不同患者个人资料对干预反应的比较.
主要成果:
- 个性化护理模式比T2DM的一般化方法更有效.
- 新诊断的患者对干预措施的反应最好.
- 血糖血红蛋白持续高 (≥10%) 的患者在实现血糖控制方面遇到最大的困难.
结论:
- 一个适合所有人的策略对于管理T2DM是不够的.
- 综合个性化监测和及时干预的以患者为中心的护理至关重要.
- 优先考虑个性化治疗策略可以减轻治疗惯性,提高护理公平性和有效性.
相关概念视频
Diabetes: Management and Pharmacotherapy
243
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
243
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Oral Hypoglycemic Agents: Biguanides and Glitazones
181
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
181
Glucagon-like Receptor Agonists
302
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
302
Carbohydrate Metabolism
10.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.8K

